Cellular heterogeneity in superficial and deep subcutaneous adipose tissues in overweight patients.
Boulet N., Estève D., Bouloumié A., Galitzky J.
Prospective Study, published in J Physiol Biochem (2012) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- J Physiol Biochem (2012)
- Country
- Spain
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 23184733
- DOI
- 10.1007/s13105-012-0225-4
- Citations
- 17
Abstract (original English)
Human abdominal adipose tissue (AAT) can be divided into two compartments according to anatomical location to dermis layer, i.e. superficial and deep compartments (sAAT and dAAT). In morbidly obese patients, dAAT mass has been linked to obesity-associated pathologies. In the present study, we characterized in overweight healthy individuals human sAAT and dAAT cellular composition and adipogenic potential. Twelve paired sAAT and dAAT samples were collected. sAAT compared to dAAT adipocytes are larger. In agreement with increased size, real-time PCR analyses performed on isolated adipocytes showed that sAAT adipocytes exhibited higher leptin transcript levels but also higher expression of genes involved in metabolism including hormone-sensitive lipase compared to dAAT adipocytes. Flow cytometry analyses performed on stroma-vascular fraction (SVF) showed no difference in the numbers of progenitor cells, endothelial cells and macrophages between sAAT and dAAT. Macrophage phenotypes were not distinct between both AAT compartments. However, CD3+ T lymphocyte number was higher in dAAT than in sAAT. Adipogenic potential of dAAT SVF was lower than sAAT SVF whereas the one of isolated progenitor cells was not distinct whatever the AAT compartments. Therefore, in overweight patients, both sAAT and dAAT compartments exhibit differences in terms of adipocytes and T lymphocyte accumulation.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.